References (Numerical)
- Ahmed M, Yassin M A (June 19, 2020) Treatment-Free Remission in
Chronic Idiopathic ThrombocytopenicPurpura. Cureus 12(6): e8705. DOI
10.7759/cureus.8705.
- Ahmed M, Yassin M A, Abdelmahmuod E (September 08, 2020)
Steroid-Refractory Chronic IdiopathicThrombocytopenic Purpura
Responding to Combination Therapy With Eltrombopag and Rituximab.
Cureus12(9): e10305. DOI 10.7759/cureus.10305
- Teofili L, Larocca LM. Advances in understanding the pathogenesis of
familial thrombocythaemia. Br J Haematol. 2011 Mar;152(6):701-12. doi:
10.1111/j.1365-2141.2010.08500.x. Epub 2011 Feb 8. PMID: 21303356.
- Olnes MJ, Scheinberg P, Calvo KR, et al, “Eltrombopag and
Improved Hematopoiesis in Refractory Aplastic Anemia,” N Engl J Med,
2012,
367(1):11-9. [PubMed 22762314]
- McHutchison JG, Dusheiko G, Schiffman ML, et al, “Eltrombopag
for Thrombocytopenia in Patients With Cirrhosis Associated With
Hepatitis C,” N Engl J Med, 2007,
357(22):2227-36. [PubMed 18046027]
- Ahmed MA, Yassin MA: Low-dose eltrombopag in a patient with chronic
idiopathicthrombocytopenic purpura post sleeve gastrectomy. Case Rep
Oncol. 2020, 13:655-658.10.1159/000507755